What are the International Classification of Diseases, 10th Revision (ICD‑10) codes for right‑sided and left‑sided hormone‑receptor‑positive breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Codes for Hormone Receptor-Positive Breast Cancer

For hormone receptor-positive breast cancer, use the primary malignant neoplasm codes with laterality specification: C50.x11 for right breast and C50.x12 for left breast, where 'x' represents the specific anatomical subsite (0-9).

Code Structure and Laterality

The ICD-10-CM coding system for breast cancer follows a hierarchical structure with mandatory 7th character extensions for laterality 1:

  • Right breast: Always ends in 1 (e.g., C50.911 for right breast, unspecified site)
  • Left breast: Always ends in 2 (e.g., C50.912 for left breast, unspecified site)
  • Bilateral: Would use 3 if applicable, though bilateral codes require separate coding for each side when no specific bilateral code exists 1

Specific Anatomical Site Codes

The complete code requires specifying the anatomical location within the breast (C50.x):

  • C50.0: Nipple and areola
  • C50.1: Central portion of breast
  • C50.2: Upper-inner quadrant
  • C50.3: Lower-inner quadrant
  • C50.4: Upper-outer quadrant
  • C50.5: Lower-outer quadrant
  • C50.6: Axillary tail
  • C50.8: Overlapping sites
  • C50.9: Breast, unspecified

Important Coding Considerations

The ICD-10 code itself does not specify hormone receptor status 2. The hormone receptor-positive designation is documented separately in the pathology report through immunohistochemistry (IHC) evaluation of ER and PR status 3. Tumors with 1-100% ER staining are considered ER-positive and eligible for endocrine therapy 2.

Common Pitfalls

  • Do not use placeholder X unless the code requires fewer than 6 characters before the 7th character laterality designation 1
  • Always verify the specific anatomical subsite rather than defaulting to "unspecified" when location is documented
  • Code each side separately for bilateral disease using the appropriate laterality digit for each tumor 1
  • Remember that ICD-10 codes identify the anatomical diagnosis only—receptor status, HER2 status, and tumor grade are documented through pathology reporting systems, not ICD-10 codes 3, 2

Clinical Context

While the ICD-10 code captures the anatomical diagnosis, treatment decisions for HR-positive breast cancer depend on the documented receptor status from pathology 4. Postmenopausal women with HR-positive disease receive aromatase inhibitors as preferred first-line endocrine therapy 4, while premenopausal women require ovarian suppression or ablation combined with endocrine therapy 4.

Related Questions

What is the appropriate ICD-10 code for hormone-receptor-positive breast cancer?
What is the appropriate ICD-10-CM code for a right-sided breast cancer that is hormone receptor positive?
What are the appropriate ICD-10 codes for a patient with malignant neoplasm of the neck, malignant neoplasm of the knee (femur), metastatic disease to both lungs, and metastatic disease to bone?
What is the ICD‑10 code for breast cancer?
What is the optimal oral systemic treatment for a 20‑year‑old premenopausal woman with early‑stage hormone‑receptor‑positive breast cancer?
What is the appropriate levofloxacin dose for an adult patient with COPD and heart failure with a left ventricular assist device (LVAD)?
How many doses of ceftriaxone should be administered for an uncomplicated bacterial wound infection?
Provide a concise five-line summary of the strongest arguments supporting influenza vaccination.
How should I manage a patient (taking lumateperone 42 mg daily, prazosin 2 mg at bedtime, mirtazapine 15 mg nightly with planned increase, propranolol 150 mg tablets – 1½ tablets in the morning and 1 tablet at bedtime, and lamotrigine 150 mg tablets – 1½ tablets in the morning and 1 tablet at bedtime) who needs help sleeping and requires a medication review after taking over care from the primary care physician?
What is the recommended treatment for cat-scratch disease presenting with fever and lymphadenitis?
Are GLP‑1 receptor agonists safe to use in a patient with Hashimoto’s thyroiditis and type 2 diabetes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.